Theriva Biologics, Inc. - TOVX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 14
Latest filed: Mar 23, 2026
| Form | Count |
|---|---|
| 8-K | 9 |
| 4 | 4 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Mar 23, 2026 | 8-K | Mar 23, 2026 | 0001104659-26-033051 | View |
| Mar 12, 2026 | 8-K | Mar 12, 2026 | 0001104659-26-026765 | View |
| Feb 18, 2026 | 8-K | Feb 17, 2026 | 0001104659-26-016792 | View |
| Feb 12, 2026 | 8-K | Feb 11, 2026 | 0001104659-26-013907 | View |
| Jan 12, 2026 | 8-K | Jan 12, 2026 | 0001104659-26-002750 | View |
| Jan 06, 2026 | 4 | Jan 05, 2026 | 0001104659-26-001381 | View |
| Jan 06, 2026 | 4 | Jan 05, 2026 | 0001104659-26-001383 | View |
| Jan 06, 2026 | 4 | Jan 05, 2026 | 0001104659-26-001384 | View |
| Jan 06, 2026 | 4 | Jan 05, 2026 | 0001104659-26-001388 | View |
| Dec 29, 2025 | 8-K | Dec 29, 2025 | 0001104659-25-124523 | View |
| Dec 15, 2025 | 8-K | Dec 15, 2025 | 0001104659-25-121246 | View |
| Nov 12, 2025 | 8-K | Nov 12, 2025 | 0001104659-25-109821 | View |
| Nov 10, 2025 | SCHEDULE 13G | — | 0002096075-25-000001 | View |
| Oct 29, 2025 | 8-K | Oct 29, 2025 | 0001104659-25-103774 | View |